Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus

Clinical and Experimental Dermatology

Volumn 21, Issue 1, 1996, Pages 38-42

  Lipka, K ^a   Tebbe, B ^a   Finckh, U ^a   Rolfs, A ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, VIRAL; BASE SEQUENCE; BLOOD CELLS; DNA; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOENZYME TECHNIQUES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RADIOIMMUNOPRECIPITATION ASSAY; VIRAL PROTEINS;

EID: 0029889480     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1996.tb00009.x     Document Type: Article

References (29)

1. Budman DR, Merchant EB, Steinberg AD et al. Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active sLE. Arthritis Rheum 1977; 20: 829 33.
2. Morimoto Ch, Abe T, Hara M et al. In vitro TNP-specific antibody formation by peripheral lymphocytes from patients with systemic lupus erythematodes. Scand J Immunol 1977; 6: 575-9.
3. Morimoto Ch, Steinberg AD, Letvin NL et al. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 1987; 79: 762-8.
4. Gottlieb AB, Lahita RG, Chiorazzi NL et al. Immune function in systemic lupus erythematosus: impairment of in vitro T cell proliferation and in vivo antibody response to exogenous antigen. J Clin Invest 1979; 63: 885-91.
5. Miyasaka N, Nakamura T, Russell IJ et al. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 31: 109-14.
6. Calabrese LH. Autoimmune manifestations of human immunodeficiency virus (HIV) infection. Clin Lab Med 1988; 8: 269-79.
7. Kopelman RG, Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988; 84: 82-8.
8. De Clerk LS, Couttenye MM, de Broe M et al. Acquired immunodeficiency syndrome mimicking Sjögrens syndrome and systemic lupus erythematosus. Arthritis Rheum 1988; 31: 272-5.
9. Miyoshi I, Kubonishi I, Yoshimoto S, Type C- virus particles in a cord T-cell line, derived hy cocultivating normal human cord leukocytes and human leukemic T-cells. Nature 1981; 294: 770-1.
10. Yoshida M, Miyoshi I, Hinuma Y. HTLV I type I (US isolate) and ATLV (Japanese isolate) are the same species of human retrovirus. Virol 1984; 133: 238-43.
11. Gessain A, Barin F, Vernant JC. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paresis. Lancet 1985; ii: 1247-9.
12. Yoshida M. Molecular biology of HTLV I from adult T-cell leukemia (ATL) and chronic myelopathy (TSP/HAM). In: Román GC, Vernant JC, Osame M, eds. HTLV I and the Nervous System, Neurology and Neurobiology, vol. 51. New York: Alan R. Liss, Inc., 1989: 19-29.
13. Yoshiki T, Mellors RC, Strand M et al. The viral envelope gycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med 1974; 140: 1011-27.
14. Olsen RG, Tarr MJ, Mathes LK et al. Serological and virological evidence of human T-lymphotropic virus in systemic lupus erythematosus. Med Microbiol Immunol 1987; 176: 53-64.
15. Lin KT, Liu MF, Hsieh RP et al. Prevalence of anti-oncogenic virus antibodies in patients with malignancies, hemophilia and systemic lupus erythematosus. J Formosan Med Assoc 1985; 84: 1025-32.
16. Boumpas DT, Popovic M, Mann DL et al. Type C retroviruses of the human T cell leukemia family are not evident in patients with systemic lupus erythematosus. Arthritis Rheum 1986; 29: 185-8.
17. Koike T, Kagami M, Takahayashi K et al. Antibodies to human T cell leukemia virus are absent in patients with systemic lupus erythematosus. Arthritis Rheum 1985; 28: 481-6.
18. Tan EM, Cohen AS, Fries F et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 15: 1271-5.
19. Rolfs A, Schuller I, Finckh U et al. PCR: Clinical Diagnostics and Research. Berlin, New York: Springer Laboratory, Springer-Verlag, 1992: 81-8.
20. Greenberg SJ, Ehrlich GD, Abbott MA et al. Detection of sequences homologous to human retroviral DNA in multiple sclerosis by gene amplification. Proc Natl Acad Sci USA 1989; 86: 2878-82.
21. Reddy EP, Sandberg-Wollheim M, Mettus RV et al. Amplification and molecular cloning of HTLV-1 sequences from DNA of multiple sclerosis patients. Science 1989; 243: 529-33.
22. Ranki A, Kurki P, Riepponen S et al. Antibodies to retroviral proteins in autoimmune connective tissue disease. Relation to clinical manifestations and ribonucleoprotein autoantibodies. Arthritis Rheum 1992; 35: 1483-91.
23. Higashi J, Kumagai S, Hatanaka M et al. The presence of antibodies to purified p24gag protein of HTLV-I in sera of patients with systemic lupus erthematosus (SLE). Virus Genes 1992; 6: 357-64.
24. Krieg AM, Gourley MF, Perl A. Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J 1992; 6: 2537-44.
25. gag antigen. Cell 1987; 51: 211-20.
26. gag protein suggests a possible cause for autoimmunity in systemic sclerosis. Proc Natl Acad Sci USA 1989; 86: 8492-6.
27. Kohsaka H, Yamamoto K, Fujii H et al. Fine epitope mapping of the human SS-B/La protein. J Clin Invest 1990; 85: 1566-74.
28. Banki K, Maceda J, Hurley E et al. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: A possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci USA 1992; 89: 1939-43.
29. Brookes SM, Pandolfino YA, Mitchell TJ et al. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol 1992; 31: 735-42.